Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0.
<p>CI = confidence interval; HR = hazard ratio; NA = not applicable; NE = not estimable; RI = relative incidence; SCRI = self-controlled risk interval. Note: Encephalitis/encephalomyelitis was not evaluated with the SCRI design because of its known high case fatality rate.</p>...
Сохранить в:
| Главный автор: | |
|---|---|
| Другие авторы: | , , , , , , , , , , , , , , , , , , , , , |
| Опубликовано: |
2025
|
| Предметы: | |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
| Итог: | <p>CI = confidence interval; HR = hazard ratio; NA = not applicable; NE = not estimable; RI = relative incidence; SCRI = self-controlled risk interval. Note: Encephalitis/encephalomyelitis was not evaluated with the SCRI design because of its known high case fatality rate.</p> |
|---|